Basically the FDA will tell them whether they can begin patient dosing or not with the stem cell treatment for Aplastic Anemia. The FDA has to always make sure the dosing is safe and right to start testing in humans. Considering BMSN is using natural endothelial cells to naturally stimulate the bone marrow to produce blood< i don't see any problems.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.